Grant Pharmacy
Hassle-Free Shopping
Live healthy
Care for your health needs
Affordable prescription drugs to all people
We respect our customer privacy
Reorder Coupons

Total Privacy

Privacy

Enjoy private and confidential shopping with complete peace of mind.

Total Security

Security

Your personal information is never shared. We follow strict security standards to keep your data safe and confidential.

Home / Gastro Health /   Ursocad (Ursodeoxycholic Acid) 150 Mg

Ursocad (Ursodeoxycholic Acid) 150 Mg

Ursocad (Ursodeoxycholic Acid) 150 Mg

Category:Gastro Health
Active substance:Ursodeoxycholic Acid 150 Mg
Prescription:Upload it in Checkout.
Manufacturer:Cadila Pharmaceuticals Ltd
Customer rate:
Share
Save

Ursocad (Ursodeoxycholic Acid) 150 Mg

PackageOur PricePer PillActions
30 Tabs
$48.30
$1.61
60 Tabs
$92.40
$1.54
Air Mail
90 Tabs
$132.30
$1.47
Air Mail
120 Tabs
$168.00
$1.40
Air Mail
180 Tabs
$239.40
$1.33
Air Mail
270 Tabs
$340.20
$1.26
Air Mail
360 Tabs
$428.40
$1.19
Air Mail

Usage

Ursocad (Ursodeoxycholic Acid) 150 Mg

 

Introduction

Ursocad (Ursodeoxycholic Acid) 150 Mg is an oral bile-acid medicine that contains 150 mg of ursodeoxycholic acid, also known as ursodiol or UDCA. The prescription may be made for certain selected cholestatic liver conditions or cholesterol gallstones where treatment with ursodeoxycholic acid is clinically indicated.

It is a small-strength product that may help in developing a weight-based treatment scheme. Ursocad is an international brand that means that although there is supporting evidence of the effectiveness of FDA-approved ursodiol products, it cannot be claimed that Ursocad itself is FDA-approved.

What is Ursocad (Ursodeoxycholic Acid) 150 Mg

Ursocad 150 mg contains Ursodeoxycholic Acid that is a naturally occurring hydrophilic bile acid found in small amounts in human bile. This agent belongs to a class of drugs that are known as bile acid preparations.

The Ursocad tablet contains 150 mg per unit and the current manufacturer’s packaging of Ursocad should be checked in order to find out whether the tablet is scored, coated or immediate-release.

Ursocad Ursodeoxycholic Acid contains the same active ingredient that is known as ursodiol in the USA, however, other formulations and brands of ursodeoxycholic acid products may differ by excipients, tablet construction, indication and instructions.

How It Works

The ursodeoxycholic acid mechanism of action depends on the condition that is being treated. In case of cholestatic liver disease, ursodeoxycholic acid increases the hydrophilic part of the bile-acid pool. This makes possible to displace the more hydrophobic bile acids that damage hepatocytes and bile-duct cells.

Furthermore, ursodeoxycholic acid increases bile secretion and supports protective cellular processes in the liver and biliary tract. This explains the role of ursodeoxycholic acid in the treatment of primary biliary cholangitis.

In selected cases, when ursodeoxycholic acid is used for the treatment of cholesterol gallstones, it reduces the secretion of cholesterol from the liver and decreases its intestinal absorption. It leads to the change of the bile composition making it less prone to crystallization.

Ursodeoxycholic acid is not the product that cleanses the liver and its action is connected with the change of bile composition and circulation in certain conditions.

Why It Is Prescribed

Indications for ursodeoxycholic acid uses may differ from country to country, form of dosage to form of dosage and product authorization. As for the US labeling, ursodiol tablets are prescribed for the treatment of primary biliary cholangitis. Certain forms of ursodiol capsules are prescribed for the treatment of certain noncalcified cholesterol gallstones and prevention of formation of gallstones in the period of fast weight loss.

Depending on the authorization and specialist opinion, ursodeoxycholic acid may be prescribed for:

  • Primary biliary cholangitis in the long-term and first-line treatment
  • Small, radiolucent, noncalcified cholesterol gallstones in case when surgery is inappropriate or refused
  • Selected cholestatic liver or biliary conditions
  • Certain pediatric hepatobiliary conditions under the supervision of a specialist
  • Intrahepatic cholestasis of pregnancy under obstetrician and hepatology specialists' care

Ursodeoxycholic acid is not effective in all cases. Calcified, radiopaque, pigment and some larger stones may not dissolve. In case of acute gallbladder inflammation, infection of bile duct, biliary obstruction, gallstone pancreatitis or any other reason for surgery, other therapy may be needed.

Why the 150 mg Tablet May Be Chosen

Ursocad UDCA 150 mg contains less amount of active ingredient per tablet than 250 mg, 300 mg, 450 mg or 500 mg products. This may allow creating a regimen that suits patients that require a smaller daily dosage.

Smaller strength of the product does not mean that this formulation is pharmacologically weaker. On the contrary, it just means that this product contributes less to the total daily amount of the active ingredient. The patient will have to use several tablets in order to obtain the required amount.

For example, two 150 mg tablets will contain 300 mg of ursodeoxycholic acid. It does not mean that two Ursocad tablets will replace a specific 300 mg capsule or extended-release tablet. Formulation and dosing regimen still should be taken into account.

Smaller strength will make the process of counting the tablets difficult. Patient should always take the number of tablets that is written in the instructions rather than assume that one tablet equals one complete dose.

How to take this medication 

Take Ursocad according to the prescription and following the instructions provided with the dispensed pack. U.S. labeled ursodiol tablets for the treatment of primary biliary cholangitis are taken with food and in divided doses. The instructions about Ursocad should be verified with its own label.

Swallow the ursodeoxycholic acid tablet with the glass of water. Do not crush, chew or divide it unless the manufacturer’s instructions or pharmacist says that Ursocad tablet can be divided.

If a dose is missed, take it as soon as you remember unless it is nearly time to take the next scheduled dose. Skip the missed dose and continue with the usual regimen. Do not take two doses at once.

Cholestyramine, colestipol and aluminum-containing antacids reduce UDCA absorption through the binding of bile acids in the intestine. Get the appropriate schedule of administration if any of these products is used.

How It Works Inside the Body

After administration, ursodeoxycholic acid is absorbed and enters the portal circulation to the liver where a large portion is extracted, conjugated with glycine or taurine and secreted into bile.

Conjugated UDCA enters the intestine and is reabsorbed and returned to the liver in enterohepatic circulation. Some of the bile acids are metabolized by the intestinal bacteria into lithocholic acid. Unabsorbed and metabolized substances are excreted mostly with feces and urinary excretion is minor.

With repeated administration, ursodeoxycholic acid is the larger component of the bile-acid pool. As UDCA constantly circulates between liver, bile, gallbladder and intestine, its conventional plasma half-life does not completely describe the duration of the effect.

Dosage Explanation

ursodeoxycholic acid 150 mg contains a certain amount of active ingredient in one tablet. It does not state how many tablets are needed to be taken each day.

According to the US ursodiol tablet labeling, 13–15 mg/kg/day for primary biliary cholangitis are recommended, being administered in divided doses with meals.

According to the US ursodiol capsule labeling, 8–10 mg/kg/day for selected gallstones should be used.

One 150 mg tablet may be the fraction of the required daily dose.

Several tablets may be prescribed, therefore, counting the tablets correctly is essential.

Ursocad is not supposed to be the automatic substitute for the products in 250 mg, 300 mg, 450 mg or 500 mg strength.

Regular and extended-release ursodeoxycholic acid tablets may require different administration schedule.

Splitting of the tablet should be done in accordance with the manufacturer’s instructions.

Kidney clearance is not the major factor of the dose determination as UDCA and its metabolites are eliminated mainly via the feces. Advanced liver or biliary condition may influence the disposition of the drug.

What to Expect During Treatment

UDCA does not cause an instant improvement of the symptoms. In case of primary biliary cholangitis, the response is evaluated on the basis of bilirubin, alkaline phosphatase, gamma-glutamyl transferase, AST and ALT results. According to the U.S. tablet labeling, liver tests should be performed monthly during the first 3 months and then every six months, but in some regions this schedule may be different.

The improvement of the symptoms like itching or fatigue does not always mean that the underlying condition is under control. Persistent symptoms also do not mean the failure of the treatment. Modern guidelines of the PBC treatment consider biochemical response, the stage of the disease, fibrosis risk and symptoms burden.

Dissolution of gallstones usually requires much time. Proper stones require 6–24 months of treatment and complete dissolution occurs not always. The imaging studies are required since improved symptoms do not confirm the disappearance of a stone. The stones may reappear after successful dissolution.

Precautions and warning

UDCA is not recommended in case of the complete biliary obstruction and for people that are hypersensitive to ursodiol, bile acids or formulation. It is not appropriate for dissolution of calcified, radiopaque or pigment gallstones.

People with Crohn’s disease, intestinal obstruction, impaired intestinal motility or surgical intervention on the gastrointestinal tract should notify the prescriber of their complete medical history.

According to the current U.S. tablet labeling, there is no evidence that available human data on pregnancy have revealed any risk of major malformations and miscarriage. However, the treatment in pregnancy should be coordinated with the hepatology and obstetricians team. Information about lactation is limited.

Presence of the 150 mg strength does not mean that Ursocad is FDA-approved for pediatric patients. The treatment of children with the appropriate indication should be prescribed and supervised by the hepatologist or other specialist with experience of treating such patients.

Side Effects

Common ursodeoxycholic acid side effects include:

  • Loose stools
  • Mild abdominal discomfort
  • Nausea or indigestion
  • Constipation
  • Headache or dizziness
  • Mild itching or skin rash
  • Hair thinning or hair loss

These effects may appear or disappear, but they should be discussed with a healthcare provider if they persist or bother the patient.

Drug Interactions

Cholestyramine and colestipol: these drugs bind bile acids in the intestine and reduce UDCA absorption.

Aluminum-containing antacids: aluminum may bind bile acids and reduce the amount of the medicine for absorption.

Estrogens and certain oral contraceptives: these drugs increase the secretion of the cholesterol into bile and may oppose the treatment of cholesterol gallstones.

Clofibrate and lipid-modifying drugs: these agents promote the appearance of the cholesterol-rich bile and make stone dissolution unlikely.

Drugs that cause cholestasis: these drugs may work in contradiction to the therapeutic goal of the treatment or complicate the interpretation of the liver test results.

Other therapies for primary biliary cholangitis: additional therapy may be considered in case of the insufficient response to UDCA, but it requires specialist care.

Ursocad (Ursodeoxycholic Acid) 150 Mg vs Alternative Treatments

The ursodeoxycholic acid market contains various brands, strengths, tablets, capsules and extended-release formulations. They are not interchangeable products.

When comparing an ursodeoxycholic acid brand name, one should check the strength, dosage form, release characteristics, indication and prescription schedule. Another product should not be chosen only because it contains the same active ingredient.

The 150 mg tablet allows using the product more flexibly, but it may need more tablets per dose. Verify the strength and required dose when refilling the prescription.

Practical Tips for Better Results

Count the tablets correctly in case several 150 mg units are needed. Take the dose at the required time relative to food and maintain the proper separation of bile-acid binding drugs.

Attend the scheduled lab appointments even if the symptoms improved. In case of Ursocad prescription for gallstones, attend all imaging appointments since imaging studies evaluate the dissolution of the stones.

Patients with a valid prescription that wish to purchase Ursocad 150 mg through Grant Pharmacy should make sure that the selected product is the same as the prescribed strength and dosage form. Contact Grant Pharmacy in order to get the current inventory, prescription requirements, destination restrictions and delivery availability. Your medication will be delivered to your doorstep based on the validity of prescription, the rules of Grant Pharmacy, destination and current delivery possibilities. After purchasing through Grant Pharmacy, examine the packing and contact Grant Pharmacy if the brand name, active ingredient, strength or formulation are not as expected according to the prescription.

Storage Instruction

Store the tablets in their original sealed packing.

Keep them at room temperature unless stated otherwise in the manufacturer’s instructions.

Protect the medicine from overheating, humidity and direct sunlight.

Do not store the tablets in the humid bathroom.

Keep all medicines out of reach and sight of children.

Do not use the tablets after the expiration date.

Keep the divided tablets only if it is stated in the manufacturer’s instructions.

FAQs

What is Ursocad 150 mg used for?

Ursocad may be prescribed for the treatment of primary biliary cholangitis or selected cholesterol gallstones, depending on its authorization in the region. Cholestatic conditions should be evaluated by specialist.

Is Ursocad the same as ursodiol?

Ursocad contains UDCA that is called ursodiol in the USA. The active ingredient is the same, but the formulations and indication may differ.

Why might a prescriber choose the 150 mg strength?

This smaller dosage unit makes it possible to develop certain weight-based regimen. More than one tablet may be needed, so the required number of tablets should be taken.

Can Ursocad be used for fatty liver?

UDCA is not the universal treatment for the steatotic liver disease that occurs due to metabolic dysfunction. The cause of the abnormalities should be found before prescribing a drug.

Can one Ursocad tablet dissolve gallstones?

The treatment of gallstones is always weight-based and certain cholesterol gallstones are suitable. One 150 mg tablet is unlikely to contain the full daily dose. Imaging is needed to evaluate the treatment response.

Can I stop Ursocad when my liver tests improve?

Improved laboratory tests may show that the treatment is effective, but it does not mean that the chronic disease, like primary biliary cholangitis, is cured. Treatment should be continued for a long time and stopped only if prescriber changed it.

Final Conclusion

Ursocad 150 mg is the smaller-strength formulation of UDCA that can allow the development of the weight-based regimen. Smaller dosage unit does not change the action of the active ingredient, but it may require several tablets.

Correct tablet counting, administration, interaction management, laboratory monitoring and imaging are the keys to the successful treatment. Any purchased product should contain the same active ingredient, strength and formulation as in the prescription.


Medically reviewed by the Grant Pharmacy Pharmacists Medical Team.


Medical References

U.S. Food and Drug Administration (FDA) – URSO 250 and URSO Forte Tablets, Prescribing Information

https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020675s028lbl.pdf

DailyMed – Ursodiol Tablets, Prescribing Information

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=55c1556b-8b47-479a-979b-fd61bdd27c7f

DailyMed – Ursodiol Capsules, Prescribing Information

https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3617fb7a-1f57-4276-bebb-ae6ba4252d4e

MedlinePlus – Ursodiol Drug Information

https://medlineplus.gov/druginfo/meds/a699047.html

Mayo Clinic – Ursodiol Oral Route

https://www.mayoclinic.org/drugs-supplements/ursodiol-oral-route/description/drg-20066618

National Health Service (NHS) Cheshire and Merseyside – Ursodeoxycholic Acid Prescribing Support Information

https://www.cheshireandmerseysideformulary.nhs.uk/docs/files/ursodeoxycholic_psi.pdf

PubMed – AISF Practice Guidance on the Treatment of Primary Biliary Cholangitis: 2026 Update

https://pubmed.ncbi.nlm.nih.gov/42493321/

 

Medical Disclaimer: The information provided on this page is for general informational purposes only and should not be considered medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using any medication or making healthcare-related decisions. Any reliance on the information provided is solely at your own risk. If you have any questions or concerns regarding the content on this website, please contact our administration team for assistance.

Author Details

Last updated 24 Sept 2026 | 06:16 AM (IST)

Reviews (0)

User Reviews

0.0
(0 Reviews)
5 stars
0
4 stars
0
3 stars
0
2 stars
0
1 stars
0

No reviews

Lowest Price Medicine
Price Match Guarantee
Medications as Promised

Newsletter